Drugs / Pacltaxel
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05201547 | Apr 2022 → Apr 2026 overdue | endometrial cancer | ARCAGY/ GINECO GROUP | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pacltaxel | “Carboplatin AUC 5-6 + Pacltaxel 175 mg/m² every 3 weeks.” NCT05201547 ↗ |